CEO, HemaCell
Fangfang Zhu
Obtained a PhD in Cell Biology from Peking University, under the supervision of Professor Deng Hongkui, and worked as a postdoctoral fellow in the laboratory of Irving Weissman, the director of the Stem Cell Institute at Stanford University and the "father of stem cells", specializing in stem cell biology and cancer immunity.
Dr. Zhu's work achievements have been reported by international scientific media such as Nature Reports, Science Daily, as well as domestic and foreign media such as Xinmin Evening News and Xinhua Daily. Dr. Zhu also worked as an early venture capitalist in the US healthcare industry at WI Harper Group.
Dr. Zhu founded Xueji Biotechnology in June 2021 and completed three rounds of financing in its first year. Dr. Zhu was the President of the Peking University Northern California Alumni Association, Secretary General and Director of the Zhejiang Chamber of Commerce in the United States.